Once upon a time Intel was a technology darling, that sadly was many moons ago as it got left behind with its rooted in the past attitude. Today it reported the fifth consecutive quarter of falling sales and the second consecutive quarter of losses. Intel reported first-quarter results on Thursday with a 133% annual reduction in earnings per share. This led to the biggest loss in the company’s history. Sadly, the terrible earnings were anticipated and even less than expected, … Continue reading “Intel Largest Quarterly Loss Ever as Revenue Collapsed 36% Over The Year, But There is Hope”
US Weekly IPO and SPAC Monitor: Following Mobileye’s Strong Debut Watch for Refreshed Filings
Following the strong debut of the Intel Mobileye IPO there are no confirmed IPOs scheduled for the week ahead but some shuffling of papers for a number of micro-caps on the calendar looking to price on a “day-to-day” basis. Often run ups in the stock market as we have seen in the past week bring a few out as brokers look to shift deals in the pipeline to investors. A feature of the IPO market this year is the many … Continue reading “US Weekly IPO and SPAC Monitor: Following Mobileye’s Strong Debut Watch for Refreshed Filings”
Self-Driving Tech Mobileye Gained 38 percent on Debut Valuing the IPO at $23 billion
Mobileye Global, Intel’s self-driving vehicle technology business shares debuted on the Nasdaq Wednesday and opened trading at $26.71, closing up 38 percent to $28.97, giving the company a market value of about $23 billion. MBLY raised $861 million by offering 41 million shares at $21, above the range of $18 to $20. INTC only floating 5% of its basic shares outstanding, well below the typical 15%, in light of current market conditions and market reaction. It listed on the Nasdaq … Continue reading “Self-Driving Tech Mobileye Gained 38 percent on Debut Valuing the IPO at $23 billion”
Intel Autonomous Driving Unit Mobileye $861 million IPO Prices Above Range
Mobileye Global, Intel’s self-driving vehicle technology business raised $861 million by offering 41 million shares at $21, above the range of $18 to $20. The IPO terms were announced last Tuesday and priced last night, a week later. INTC was sold off briskly on the news as the number was far below expectations of the $30 billion figure Intel had flouted about a month ago. The company is only floating 5% of its basic shares outstanding, well below the typical … Continue reading “Intel Autonomous Driving Unit Mobileye $861 million IPO Prices Above Range”
US Weekly IPO and SPAC Monitor: Intel’s Mobileye, Biotech’s ASP Isotopes and Intensity Therapeutics
A feature of the IPO market this year is the many names coming up for pricing and being delayed. No surprise with 87% issued in the last year down according to Dealogic. We have the Intel Mobileye IPO listing this week. MBLY is only floating 5% of its basic shares outstanding, well below the typical 15% after the market took to INTC last week. Two holdovers are also expected to debut in the week ahead. Isotope enrichment company ASP Isotopes … Continue reading “US Weekly IPO and SPAC Monitor: Intel’s Mobileye, Biotech’s ASP Isotopes and Intensity Therapeutics”
US Weekly IPO and SPAC Monitor: Gene editing Biotech Prime Medicine and Molybdenum Enricher Aerodynamic Separation Process
We are seeing a little activity in IPO land. A few deals are scheduled to price in the week ahead, and many still on the back burner. Gene editing biotech Prime Medicine (PRME) would be the first sizable IPO of the fourth quarter. Aerodynamic Separation Process (ASP) focusing on the commercialization of enriched Molybdenum-100 plans to list. Three holdovers from the past week are scheduled to price; Beamr Imaging (BMR), Intensity Therapeutics (INTS) and Alopexx (ALPX). Intel’s Mobileye (MBLY) will … Continue reading “US Weekly IPO and SPAC Monitor: Gene editing Biotech Prime Medicine and Molybdenum Enricher Aerodynamic Separation Process”
US Weekly IPO and SPAC Monitor: Biotech Alopexx, Software Companies Beamr and Castellum
The IPO drought continues to worsen along with global liquidity. Fund managers, investors and deal makers are obviously reluctant to wade into new IPOs. On the agenda is Beamr (BMR), an Israeli video encoding and image optimization software provider, OTC-listed intelligence analysis, software development company Castellum (CTM) and infectious disease biotech Alopexx (ALPX). The fourth quarter started off quietly week with just one SPAC priced and three small issuers submitted initial filings. A new SPAC plans to target the new … Continue reading “US Weekly IPO and SPAC Monitor: Biotech Alopexx, Software Companies Beamr and Castellum”
US Weekly IPO and SPAC Monitor: Intel’s Mobileye Filed for an IPO in Quiet Period
No surprise after the disaster of the three major US stock indexes ugly closes Friday to finish off a disastrous September and the IPO market there are currently no IPOs scheduled for the first week of October. The biggest news of the week came from Intel’s Mobileye (MBLY), which filed for an IPO we estimate could raise up to $2.5 billion. The third quarter was worst third quarter for new issuers in over a decade, with 25 IPOs raising $2.4 billion as … Continue reading “US Weekly IPO and SPAC Monitor: Intel’s Mobileye Filed for an IPO in Quiet Period”